Company: ATRA
Filing Date: 2025-08-11
Form Type: 8-K
Source: 0000950170-25-106533
Chunk: 0

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-08-11
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On August 11, 2025, the Company announced certain financial results for the second quarter ended June 30, 2025. A copy of the Company’s press release, titled “ Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress” is furnished as Exhibit 99.1 hereto.

The information set forth in this Item 2.02 and in the press release included as Exhibit 99.1 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any filing with the U. S. Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing.